Abstract
The effect of timolol versus propranolol on hypertension, hemodynamics, and plasms renin activity was evaluated in 20 men. After two weeks of placebo, 11 men received timolol 30 to 60 mg daily, and nine men received propranolol, 240 to 480 mg daily, for five weeks in a double-blind randomized study. The 20 men then received placebo again for two weeks. Right heart catheterization was performed in all 20 patients after two weeks of the first placebo and after five weeks of timolol or propranolol. Equipotent doses of timolol and propranolol were equally effective in significantly lowering supine and upright systolic and diastolic blood pressure and heart rate recorded on an outpatient basis. Equipotent doses of timolol and propranolol caused similar hemodynamic effects including similar significant depression of cardiac index. Equipotent doses of timolol and propranolol caused similar marked depression of plasma renin activity. The hypotensive action of timolol and of propranolol was unrelated to their effect on plasma renin activity.
References
Jan 9, 1975·The New England Journal of Medicine·E L BravoH P Dustan
Apr 1, 1975·American Heart Journal·G Lohmöller, E D Frohlich
Aug 1, 1975·Clinical Pharmacology and Therapeutics·J A Franciosa, E D Freis
Oct 31, 1975·The American Journal of Cardiology·F R BühlerM Pfisterer
Apr 1, 1975·British Journal of Clinical Pharmacology·T O MorganA E Doyle
Jun 1, 1975·Circulation Research·G G GeyskesE J Mees
Nov 6, 1975·The New England Journal of Medicine·J Koch-Weser
Jan 12, 1974·British Medical Journal·G S StokesI R Thornell
Oct 1, 1969·The Journal of Clinical Endocrinology and Metabolism·E HaberA Purnode
Mar 23, 1972·The New England Journal of Medicine·R ZacestJ Koch-Weser
Jun 1, 1974·Archives of Internal Medicine·J Koch-Weser
Apr 1, 1973·Minerva cardioangiologica·B MagnaniM Sanguinetti
May 1, 1973·British Heart Journal·P A MajidS H Taylor
Sep 20, 1973·The American Journal of Cardiology·F R BühlerL Baer
Sep 1, 1973·Acta Endocrinologica·K G ThorngrenA Stenström
May 1, 1974·Clinical Pharmacology and Therapeutics·M D Esler
May 1, 1972·The American Journal of Cardiology·R C Tarazi, H P Dustan
Dec 14, 1972·The New England Journal of Medicine·F R BühlerH R Brunner
Mar 1, 1968·Circulation·E D FrohlichI H Page
Jan 4, 1969·British Medical Journal·B N Prichard, P M Gillam
Citations
Nov 1, 1978·Journal of Clinical Pharmacology·T IshizakiH Nakaya
Nov 1, 1978·Journal of Clinical Pharmacology·T IshizakiH Nakaya
Dec 18, 1978·European Journal of Clinical Pharmacology·O F ElseI R Edwards
Oct 25, 1979·The New England Journal of Medicine·I M Katz
Jun 17, 1982·The New England Journal of Medicine·W H Frishman
Jul 1, 1981·British Heart Journal·J FerlinzW S Aronow
Jul 1, 1978·American Journal of Ophthalmology·W P BogerD Pavan-Langston
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·M A van BaakJ F Smits
Mar 1, 1978·Ophthalmology·W P BogerD P Langston
Jan 1, 1991·Psychosomatics·P J Mills, J E Dimsdale
Jan 1, 1979·Current Problems in Cardiology·C V Ram, N M Kaplan
Nov 10, 1983·The American Journal of Cardiology·U Thadani
Jun 1, 1983·International Journal of Cardiology·M D EzriM E Josephson
Jan 1, 1982·British Journal of Clinical Pharmacology·A J Man in 't Veld, M A Schalekamp
Mar 1, 1980·Clinical and Experimental Pharmacology & Physiology·A ScriabineN R Bohidar
Nov 1, 1981·Pharmacotherapy·F G Dunn, E D Frohlich
Apr 1, 1979·British Journal of Clinical Pharmacology·P Lund-Johansen